RxDoctor Payments DataLook up a doctor →

Pamela van Bevern, PA

Medical · Belleville, ILNPI 1407970395

Payments from drug & device makers

$9,691in general payments, 2019–2025

Across 675 payments — averaging $14.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Novo Nordisk$877
  • Lilly USA, LLC$780
  • Pfizer$651
  • Teva Pharmaceuticals USA, Inc.$624
  • plus $4K from 43 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)79$1,614
AbbVie85$1,293
Novo Nordisk83$877
Lilly USA, LLC55$780
Pfizer65$651
Teva Pharmaceuticals USA, Inc.77$624
Johnson & Johnson26$488
GSK17$280
Boehringer Ingelheim19$277
Amgen16$274
Bayer11$212
Biohaven Pharmaceutical Holding Company Ltd.18$191
Tris Pharma Inc9$173
Dexcom, Inc.9$138
Sumitomo Pharma America, Inc.7$130
Takeda Pharmaceuticals U.S.A., Inc.7$123
Abbott5$107
Exact Sciences5$106
Astellas Pharma US Inc5$101
Lundbeck LLC5$97
Nestle Healthcare Nutrition Inc.7$93
Amarin Pharma, Inc.6$87
Biohaven Pharmaceuticals, Inc.6$83
Novartis5$82
Eisai Inc.5$76
Sanofi-aventis U.S. LLC4$67
Corcept Therapeutics3$61
Merck3$51
Radius Health, Inc.2$50
Sunovion Pharmaceuticals Inc.3$46
Edwards Lifesciences2$45
Genentech USA, Inc.3$43
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$42
Neurocrine Biosciences, Inc.2$39
Azurity Pharmaceuticals, Inc.2$34
Almatica Pharma LLC2$32
Arbor Pharmaceuticals, Inc.2$28
Verity Pharmaceuticals Inc.1$26
Aimmune Therapeutics, Inc.1$23
Shield Therapeutics Inc1$19
Ironwood Pharmaceuticals, Inc1$17
Currax Pharmaceuticals LLC1$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Acerus Pharmaceuticals Corporation1$15
Ironshore Pharmaceuticals Inc.1$15
Mannkind Corporation1$13
Daiichi Sankyo Inc.1$13
IBSA Pharma Inc.1$12
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$9,691 in reported general payments places this provider in the 95th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois →

Medicare billing

Part B allowed, 2024
$44,528
Medicare patients
226
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Belleville

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →